BioAge Labs, Inc (BIOA)

BioAge Labs, Inc (BIOA) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $222M; returns 1 day -7.8%, 1 week +5.4%, 1 year -35.8%.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutic candidates for metabolic diseases by targeting the fundamental biology of human aging.

Groups BIOA belongs to

• Clinical Stage Biotech
• Biotechnology
• Biopharmaceutical
• Metabolic Disorders
• Healthcare
• Life Sciences
• Clinical Stage
• Drug Discovery
• Weight Management

BIOA financial model: income statement, cash flow and balance sheet